Sri Lanka Journal of Diabetes Endocrinology and Metabolism (Apr 2019)

Visual vignette- Nelson’s syndrome: a giant pituitary

  • Mahesh Doddabelavangala Mruthyunjaya,
  • Senthil Kumar,
  • Riddhi Das Gupta,
  • Deepak Abraham,
  • Ari George Chacko,
  • Sunithi Mani,
  • B. Rajesh,
  • Nihal Thomas

DOI
https://doi.org/10.4038/sjdem.v9i1.7375
Journal volume & issue
Vol. 9, no. 1
pp. 55 – 58

Abstract

Read online

Nelson’s syndrome is an infrequent pituitary mass with an incidence of 8–43% in adults and 25–66% in children that develops following total bilateral adrenalectomy (TBA) for the treatment of Cushing’s disease. It is one of the most challenging of all endocrine conditions. The frequent aggressiveness of the underlying ACTH-secreting pituitary adenoma (corticotrophinoma) necessitates regular biochemical and radiological screening. Current evidence favours a lack of prophylactic neoadjuvant pituitary radiotherapy at the time of TBA and a rapid rise of ACTH levels in the year post TBA as factors that may predict the occurrence of Nelson’s syndrome. Though, computerized tomography (CT)/magnetic resonance imaging (MRI) have led to the early diagnosis and improvement in management. Nelson’s related tumours are sometimes detected late, through clinical manifestations of invasion and compression of the surrounding structures. With this perspective in mind, we describe a 22 year old gentleman 10 years after TBA who presented with right sided hemiparesis due to a corticotroph adenoma.

Keywords